Assignee
LA JOLLA PHARMA CO
US·3 granted patents·12 pending applications·16 citations·filing 2014–2021
Top patents by PatentIndex Score
15 records- 0190US9457059B2Compositions and methods for treating renal failureLA JOLLA PHARMA CO·Filed 2014·Granted Oct 4, 2016·16 cites·20 claims
- 0268US2022193183A1Compositions and methods for treating renal failureLA JOLLA PHARMA CO·Filed 2021·Application pending·0 cites
- 0363US2018311306A1Methods for treating hypotensionLA JOLLA PHARMA CO·Filed 2018·Application pending·0 cites
- 0460US10294504B2Mutant endoglycoceramidases with enhanced synthetic activityLA JOLLA PHARMA CO·Filed 2015·Granted May 21, 2019·0 cites·16 claims
- 0560US2016346317A1Composition and Uses of Galectin AntagonistsLA JOLLA PHARMA CO·Filed 2016·Application pending·0 cites
- 0656US10555959B2Glycolipids as treatment for diseaseLA JOLLA PHARMA CO·Filed 2015·Granted Feb 11, 2020·0 cites·10 claims
- 0751US2019240292A1Methods of administering hepcidinLA JOLLA PHARMA CO·Filed 2019·Application pending·0 cites
- 0850US2017014471A1Compositions and methods for treating renal failureLA JOLLA PHARMA CO·Filed 2016·Application pending·0 cites
- 0946US2021128690A1Methods of administering hepcidinLA JOLLA PHARMA CO·Filed 2017·Application pending·0 cites
- 1046US2019336583A1Compositions and methods for treating iron overloadLA JOLLA PHARMA CO·Filed 2018·Application pending·0 cites
- 1145US2019315821A1Compositions comprising hepcidin and methods of use thereofLA JOLLA PHARMA CO·Filed 2019·Application pending·0 cites
- 1245US2018099023A1Methods of treating iron overloadLA JOLLA PHARMA CO·Filed 2017·Application pending·0 cites
- 1345US2017246256A1Methods of administering hepcidinLA JOLLA PHARMA CO·Filed 2017·Application pending·0 cites
- 1438US2017218005A1Compositions and methods related to gentamicinLA JOLLA PHARMA CO·Filed 2017·Application pending·0 cites
- 1538US2017014446A1Compositions and methods for administering galectin antagonistsLA JOLLA PHARMA CO·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →